share_log

Canaccord Genuity Assumes Beauty Health at Buy, Announces Price Target of $10

Benzinga ·  Aug 25, 2023 17:10

Canaccord Genuity analyst Kyle Rose assumes Beauty Health (NASDAQ:SKIN) with a Buy rating and announces Price Target of $10.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment